Global, Multicenter, Phase II Single-Arm Study of MEDI4736 Monotherapy Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: ASTRAZENECA AB
- Phase: II
- Execution start: 30/04/2015
- End of execution: 30/07/2017
- PI: JOAQUINA MARTINEZ GALAN